{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:23:12Z","timestamp":1785514992432,"version":"3.56.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Energy metabolism plays a pivotal role in cancer clinical treatment and has become an important means of clinical diagnosis of tumour progression. However, current research mostly focuses on changes in metabolic products and neglects the deeper mechanisms of transcriptional regulation. This paper proposes a new perspective, establishing a comprehensive network that reveals the interaction between metabolism and transcription, which explores how tumour metabolism affects tumour progression through transcriptional modifications, and provides a novel approach for optimizing tumour treatment strategies. This viewpoint is conducive to overcoming current bottlenecks in treatment and promoting the development of drug combinations and personalized medicine.<\/jats:p>","DOI":"10.1038\/s41419-025-07429-y","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:09:11Z","timestamp":1739848151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u201cFriends or foes\u201d: a new perspective of tumour metabolic transcriptional modification"],"prefix":"10.1038","volume":"16","author":[{"given":"Tong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jienan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5601-9670","authenticated-orcid":false,"given":"Cheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"7429_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06931-z","volume":"15","author":"L Zhao","year":"2024","unstructured":"Zhao L, Li Q, Zhou T, Liu X, Guo J, Fang Q, et al. Role of N6-methyladenosine in tumor neovascularization. Cell Death Dis. 2024;15:563.","journal-title":"Cell Death Dis"},{"key":"7429_CR2","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41419-024-06956-4","volume":"15","author":"M Pang","year":"2024","unstructured":"Pang M, Yu L, Li X, Lu C, Xiao C, Liu Y. A promising anti-tumor targeting on ERMMDs mediated abnormal lipid metabolism in tumor cells. Cell Death Disease. 2024;15:562.","journal-title":"Cell Death Disease"},{"key":"7429_CR3","doi-asserted-by":"publisher","first-page":"1119.","DOI":"10.3390\/cancers12051119","volume":"12","author":"S Cassim","year":"2020","unstructured":"Cassim S, Vucetic M, Zdralevic M, Pouyssegur J. Warburg and beyond: the power of mitochondrial metabolism to collaborate or replace fermentative glycolysis in cancer. Cancers (Basel). 2020;12:1119.","journal-title":"Cancers (Basel)"},{"key":"7429_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01704-8","volume":"22","author":"X Cao","year":"2023","unstructured":"Cao X, Geng Q, Fan D, Wang Q, Wang X, Zhang M, et al. m(6)A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion. Mol Cancer. 2023;22:42.","journal-title":"Mol Cancer"},{"key":"7429_CR5","doi-asserted-by":"crossref","unstructured":"Rodriguez-Enriquez S, Marin-Hernandez A, Gallardo-Perez JC, Pacheco-Velazquez SC, Belmont-Diaz JA, Robledo-Cadena DX, et al. Transcriptional regulation of energy metabolism in cancer cells. Cells. 2019;8:1225.","DOI":"10.3390\/cells8101225"},{"key":"7429_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:70.","journal-title":"Signal Transduct Target Ther"},{"key":"7429_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","volume":"15","author":"Q Wu","year":"2022","unstructured":"Wu Q, You L, Nepovimova E, Heger Z, Wu W, Kuca K, et al. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J Hematol Oncol. 2022;15:77.","journal-title":"J Hematol Oncol"},{"key":"7429_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721\u201332.","journal-title":"Nat Rev Cancer"},{"key":"7429_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","volume":"32","author":"A Palazon","year":"2017","unstructured":"Palazon A, Tyrakis PA, Macias D, Veli\u00e7a P, Rundqvist H, Fitzpatrick S, et al. An HIF-1\u03b1\/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell. 2017;32:669\u201383.e5.","journal-title":"Cancer Cell"},{"key":"7429_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155290","volume":"125","author":"YM Zhang","year":"2024","unstructured":"Zhang YM, Miao ZM, Chen YP, Song ZB, Li YY, Liu ZW, et al. Ononin promotes radiosensitivity in lung cancer by inhibiting HIF-1\u03b1\/VEGF pathway. Phytomedicine. 2024;125:155290.","journal-title":"Phytomedicine"},{"key":"7429_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.molcel.2012.09.028","volume":"48","author":"W Yang","year":"2012","unstructured":"Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L, et al. EGFR-induced and PKC epsilon monoubiquitylation-dependent NF-kappa B activation upregulates PKM2 expression and promotes tumorigenesis. Mol Cell. 2012;48:771\u201384.","journal-title":"Mol Cell"},{"key":"7429_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.phrs.2018.03.015","volume":"131","author":"AS Gomes","year":"2018","unstructured":"Gomes AS, Ramos H, Soares J, Saraiva L. p53 and glucose metabolism: an orchestra to be directed in cancer therapy. Pharmacol Res. 2018;131:75\u201386.","journal-title":"Pharmacol Res"},{"key":"7429_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41416-019-0640-1","volume":"122","author":"M Sola-Penna","year":"2020","unstructured":"Sola-Penna M, Paix\u00e3o LP, Branco JR, Ochioni AC, Albanese JM, Mundim DM, et al. Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the Jak1\/STAT3\/ERK1\/2 and adenylate cyclase\/PKA, respectively. Br J Cancer. 2020;122:194\u2013208.","journal-title":"Br J Cancer"},{"key":"7429_CR14","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1002\/jcb.27947","volume":"120","author":"A Yao","year":"2019","unstructured":"Yao A, Xiang Y, Si Y-R, Fan L-J, Li J-P, Li H, et al. PKM2 promotes glucose metabolism through a let-7a-5p\/Stat3\/hnRNP-A1 regulatory feedback loop in breast cancer cells. Journal Cell Biochem. 2019;120:6542\u201354.","journal-title":"Journal Cell Biochem"},{"key":"7429_CR15","doi-asserted-by":"publisher","first-page":"e20190613.","DOI":"10.1084\/jem.20190613","volume":"217","author":"LEA Damasceno","year":"2020","unstructured":"Damasceno LEA, Prado DS, Veras FP, Fonseca MM, Toller-Kawahisa JE, Rosa MH. PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation. J Exp Med. 2020;217:e20190613.","journal-title":"J Exp Med"},{"key":"7429_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri.2016.112","volume":"16","author":"W Chen","year":"2016","unstructured":"Chen W, Ten Dijke P. Immunoregulation by members of the TGF\u03b2 superfamily. Nat Rev Immunol. 2016;16:723\u201340.","journal-title":"Nat Rev Immunol"},{"key":"7429_CR17","doi-asserted-by":"publisher","first-page":"634.","DOI":"10.3390\/cells10030634","volume":"10","author":"J Padilla","year":"2021","unstructured":"Padilla J, Lee J. A novel therapeutic target, BACH1, regulates cancer metabolism. Cells. 2021;10:634.","journal-title":"Cells"},{"key":"7429_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01275-y","volume":"20","author":"M Shao","year":"2020","unstructured":"Shao M, Zhang J, Zhang J, Shi H, Zhang Y, Ji R, et al. SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis. Cancer Cell Int. 2020;20:188.","journal-title":"Cancer Cell Int"},{"key":"7429_CR19","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.3892\/or.2017.5554","volume":"37","author":"M Ye","year":"2017","unstructured":"Ye M, He Y, Lin H, Yang S, Zhou Y, Zhou L, et al. High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression. Oncol Rep. 2017;37:2955\u201363.","journal-title":"Oncol Rep"},{"key":"7429_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13046-020-1533-0","volume":"39","author":"Q Huang","year":"2020","unstructured":"Huang Q, Li S, Hu X, Sun M, Wu Q, Dai H, et al. Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation. J Exp Clin Cancer Res. 2020;39:25.","journal-title":"J Exp Clin Cancer Res"},{"key":"7429_CR21","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1111\/febs.14201","volume":"284","author":"A Rodr\u00edguez-Garc\u00eda","year":"2017","unstructured":"Rodr\u00edguez-Garc\u00eda A, Sams\u00f3 P, Fontova P, Simon-Molas H, Manzano A, Casta\u00f1o E, et al. TGF-\u03b21 targets Smad, p38 MAPK, and PI3K\/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells. Febs j. 2017;284:3437\u201354.","journal-title":"Febs j"},{"key":"7429_CR22","doi-asserted-by":"publisher","first-page":"eaax4067.","DOI":"10.1126\/scisignal.aax4067","volume":"12","author":"X Yin","year":"2019","unstructured":"Yin X, Choudhury M, Kang JH, Schaefbauer KJ, Jung MY, Andrianifahanana M, et al. Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-\u03b2. Sci Signal. 2019;12:eaax4067.","journal-title":"Sci Signal"},{"key":"7429_CR23","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.7150\/thno.37383","volume":"10","author":"E Fang","year":"2020","unstructured":"Fang E, Wang X, Wang J, Hu A, Song H, Yang F, et al. Therapeutic targeting of YY1\/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression. Theranostics. 2020;10:1555\u201371.","journal-title":"Theranostics"},{"key":"7429_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cell.2019.06.005","volume":"178","author":"C Wiel","year":"2019","unstructured":"Wiel C, Le Gal K, Ibrahim MX, Jahangir CA, Kashif M, Yao H, et al. BACH1 Stabilization by antioxidants stimulates lung cancer metastasis. Cell. 2019;178:330\u201345.e22.","journal-title":"Cell"},{"key":"7429_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107141","volume":"202","author":"Z Liao","year":"2024","unstructured":"Liao Z, Cai X, Zheng Y, Lin J, Yang X, Lin W, et al. Sirtuin 1 in osteoarthritis: Perspectives on regulating glucose metabolism. Pharmacol Res. 2024;202:107141.","journal-title":"Pharmacol Res"},{"key":"7429_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116898","volume":"318","author":"T Yang","year":"2024","unstructured":"Yang T, Liu X, Zhou Y, Du L, Fu Y, Luo Y, et al. Sanpian decoction ameliorates cerebral ischemia-reperfusion injury by regulating SIRT1\/ERK\/HIF-1\u03b1 pathway through in silico analysis and experimental validation. J Ethnopharmacol. 2024;318:116898.","journal-title":"J Ethnopharmacol"},{"key":"7429_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110192","volume":"119","author":"Y He","year":"2023","unstructured":"He Y, Wang Y, Jia X, Li Y, Yang Y, Pan L, et al. Glycolytic reprogramming controls periodontitis-associated macrophage pyroptosis via AMPK\/SIRT1\/NF-\u03baB signaling pathway. Int Immunopharmacol. 2023;119:110192.","journal-title":"Int Immunopharmacol"},{"key":"7429_CR28","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.7150\/ijbs.76704","volume":"19","author":"Z Wei","year":"2023","unstructured":"Wei Z, Xia J, Li J, Cai J, Shan J, Zhang C, et al. SIRT1 promotes glucolipid metabolic conversion to facilitate tumor development in colorectal carcinoma. Int J Biol Sci. 2023;19:1925\u201340.","journal-title":"Int J Biol Sci"},{"key":"7429_CR29","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/ptr.8115","volume":"38","author":"Y Park","year":"2024","unstructured":"Park Y, Lee HJ, Sim DY, Park JE, Ahn CH, Park SY, et al. Inhibition of glycolysis and SIRT1\/GLUT1 signaling ameliorates the apoptotic effect of Leptosidin in prostate cancer cells. Phytother Res. 2024;38:1235\u201344.","journal-title":"Phytother Res"},{"key":"7429_CR30","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/2326-6066.CIR-23-0786","volume":"12","author":"Y Hou","year":"2024","unstructured":"Hou Y, Cao Y, He Y, Dong L, Zhao L, Dong Y, et al. SIRT3 negatively regulates TFH-cell differentiation in cancer. Cancer Immunol Res. 2024;12:891\u2013904.","journal-title":"Cancer Immunol Res"},{"key":"7429_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.113757","volume":"241","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yang H, Chen S, Lu Z, Li B, Jiang T, et al. SIRT1 regulated hexokinase-2 promoting glycolysis is involved in hydroquinone-enhanced malignant progression in human lymphoblastoid TK6 cells. Ecotoxicol Environ Saf. 2022;241:113757.","journal-title":"Ecotoxicol Environ Saf"},{"key":"7429_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04632-z","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang H, Wei H, Wang H, Wang Z, Li J, Ou Y, et al. Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer. Cell Death Dis. 2022;13:206.","journal-title":"Cell Death Dis"},{"key":"7429_CR33","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.7150\/thno.56490","volume":"11","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Lin F, Wan T, Chen A, Wang H, Jiang B, et al. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM. Theranostics. 2021;11:5926\u201338.","journal-title":"Theranostics"},{"key":"7429_CR34","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/gutjnl-2023-331467","volume":"73","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Dunbar KB, Odze RD, Agoston AT, Wang X, Su T, et al. Hypoxia-inducible factor-1\u03b1 mediates reflux-induced epithelial-mesenchymal plasticity in Barrett\u2019s oesophagus patients. Gut. 2024;73:1269\u201379.","journal-title":"Gut"},{"key":"7429_CR35","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/s41388-018-0382-1","volume":"37","author":"SJ Deng","year":"2018","unstructured":"Deng SJ, Chen HY, Ye Z, Deng SC, Zhu S, Zeng Z, et al. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018;37:5811\u201328.","journal-title":"Oncogene"},{"key":"7429_CR36","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1172\/JCI72171","volume":"124","author":"Y Yang","year":"2014","unstructured":"Yang Y, Ahn YH, Chen Y, Tan X, Guo L, Gibbons DL, et al. ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. J Clin Investig. 2014;124:2696\u2013708.","journal-title":"J Clin Investig"},{"key":"7429_CR37","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1111\/jcmm.16539","volume":"25","author":"L Li","year":"2021","unstructured":"Li L, Feng Y, Hu S, Du Y, Xu X, Zhang M, et al. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN\/PI3K\/AKT signalling pathway by combining with P53. J Cell Mol Med. 2021;25:5295\u2013304.","journal-title":"J Cell Mol Med"},{"key":"7429_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jare.2024.02.022","volume":"68","author":"P Bhartiya","year":"2024","unstructured":"Bhartiya P, Jaiswal A, Negi M, Kaushik N, Ha Choi E, Kumar Kaushik N. Unlocking melanoma suppression: insights from plasma-induced potent miRNAs through PI3K-AKT-ZEB1 axis. J Adv Res. 2024;68:147\u2013161.","journal-title":"J Adv Res"},{"key":"7429_CR39","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","volume":"69","author":"C Liang","year":"2020","unstructured":"Liang C, Shi S, Qin Y, Meng Q, Hua J, Hu Q, et al. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer. Gut. 2020;69:888\u2013900.","journal-title":"Gut"},{"key":"7429_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03914-5","volume":"9","author":"L Zhou","year":"2018","unstructured":"Zhou L, Wang Y, Zhou M, Zhang Y, Wang P, Li X, et al. HOXA9 inhibits HIF-1alpha-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. Nat Commun. 2018;9:1480.","journal-title":"Nat Commun"},{"key":"7429_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00109-014-1181-y","volume":"92","author":"S Bhatlekar","year":"2014","unstructured":"Bhatlekar S, Fields JZ, Boman BM. HOX genes and their role in the development of human cancers. J Mol Med. 2014;92:811\u201323.","journal-title":"J Mol Med"},{"key":"7429_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13046-019-1106-2","volume":"38","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Tang B, Song J, Yu S, Li Y, Su H, et al. Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression. J Exp Clin Cancer Res. 2019;38:92.","journal-title":"J Exp Clin Cancer Res"},{"key":"7429_CR43","doi-asserted-by":"publisher","first-page":"26765","DOI":"10.18632\/oncotarget.8503","volume":"7","author":"Z Wang","year":"2016","unstructured":"Wang Z, Xie J, Yan M, Wang J, Wang X, Zhang J, et al. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma. Oncotarget. 2016;7:26765\u201379.","journal-title":"Oncotarget"},{"key":"7429_CR44","doi-asserted-by":"publisher","first-page":"e5577","DOI":"10.1371\/journal.pone.0005577","volume":"4","author":"J Lu","year":"2009","unstructured":"Lu J, Jeong HW, Kong N, Yang Y, Carroll J, Luo HR, et al. Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex. PLoS One. 2009;4:e5577.","journal-title":"PLoS One"},{"key":"7429_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3935","volume":"4","author":"C Zhang","year":"2013","unstructured":"Zhang C, Liu J, Liang Y, Wu R, Zhao Y, Hong X, et al. Tumour-associated mutant p53 drives the Warburg effect. Nat Commun. 2013;4:2935.","journal-title":"Nat Commun"},{"key":"7429_CR46","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1002\/jcp.27354","volume":"234","author":"I Hern\u00e1ndez-Res\u00e9ndiz","year":"2019","unstructured":"Hern\u00e1ndez-Res\u00e9ndiz I, Gallardo-P\u00e9rez JC, L\u00f3pez-Macay A, Robledo-Cadena DX, Garc\u00eda-Villa E, Gariglio P, et al. Mutant p53(R248Q) downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells. J Cell Physiol. 2019;234:5524\u201336.","journal-title":"J Cell Physiol"},{"key":"7429_CR47","doi-asserted-by":"crossref","unstructured":"Kanapathipillai M. Treating p53 mutant aggregation-associated cancer. Cancers. 2018;10:154.","DOI":"10.3390\/cancers10060154"},{"key":"7429_CR48","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41423-021-00806-5","volume":"19","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Fan G, Liu Y, Liu L, Zhang T, Liu P, et al. The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis. Cell Mol Immunol. 2022;19:504\u201315.","journal-title":"Cell Mol Immunol"},{"key":"7429_CR49","doi-asserted-by":"crossref","unstructured":"Akash MSH, Rasheed S, Rehman K, Ibrahim M, Imran M, Assiri MA. Biochemical activation and regulatory functions of trans-regulatory KLF14 and Its association with genetic polymorphisms. Metabolites. 2023;13:199.","DOI":"10.3390\/metabo13020199"},{"key":"7429_CR50","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1073\/pnas.1818539116","volume":"116","author":"XJ Chen","year":"2019","unstructured":"Chen XJ, Zhang WN, Chen B, Xi WD, Lu Y, Huang JY, et al. Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-\u03baB repressing factor. Proc Natl Acad Sci USA. 2019;116:2220\u201325.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7429_CR51","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/onc.2014.118","volume":"34","author":"LH Tsai","year":"2015","unstructured":"Tsai LH, Wu JY, Cheng YW, Chen CY, Sheu GT, Wu TC, et al. The MZF1\/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss. Oncogene. 2015;34:1641\u20139.","journal-title":"Oncogene"},{"key":"7429_CR52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature16498","volume":"529","author":"K Wilhelm","year":"2016","unstructured":"Wilhelm K, Happel K, Eelen G, Schoors S, Oellerich MF, Lim R, et al. FOXO1 couples metabolic activity and growth state in the vascular endothelium. Nature. 2016;529:216\u201320.","journal-title":"Nature"},{"key":"7429_CR53","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin A, Gil-de-G\u00f3mez L, Dahiya S, Jiao J, Guo L, Levine MH, et al. Foxp3 Reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 2017;25:1282\u201393.e7.","journal-title":"Cell Metab"},{"key":"7429_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.279","volume":"11","author":"XH Wang","year":"2021","unstructured":"Wang XH, Jiang ZH, Yang HM, Zhang Y, Xu LH. Hypoxia-induced FOXO4\/LDHA axis modulates gastric cancer cell glycolysis and progression. Clin Transl Med. 2021;11:e279.","journal-title":"Clin Transl Med"},{"key":"7429_CR55","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","volume":"19","author":"A Dey","year":"2020","unstructured":"Dey A, Varelas X, Guan KL. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 2020;19:480\u201394.","journal-title":"Nat Rev Drug Discov"},{"key":"7429_CR56","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.15252\/embj.201490379","volume":"34","author":"E Enzo","year":"2015","unstructured":"Enzo E, Santinon G, Pocaterra A, Aragona M, Bresolin S, Forcato M, et al. Aerobic glycolysis tunes YAP\/TAZ transcriptional activity. EMBO J. 2015;34:1349\u201370.","journal-title":"EMBO J"},{"key":"7429_CR57","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13046-020-01705-9","volume":"39","author":"Z Sun","year":"2020","unstructured":"Sun Z, Zhang Q, Yuan W, Li X, Chen C, Guo Y, et al. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo\/YAP1\/HIF1A axis. J Exp Clin Cancer Res. 2020;39:250.","journal-title":"J Exp Clin Cancer Res"},{"key":"7429_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.83","volume":"6","author":"Y Gao","year":"2017","unstructured":"Gao Y, Yang Y, Yuan F, Huang J, Xu W, Mao B, et al. TNF\u03b1-YAP\/p65-HK2 axis mediates breast cancer cell migration. Oncogenesis. 2017;6:e383.","journal-title":"Oncogenesis"},{"key":"7429_CR59","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1073\/pnas.1311249111","volume":"111","author":"HJ Wang","year":"2014","unstructured":"Wang HJ, Hsieh YJ, Cheng WC, Lin CP, Lin YS, Yang SF, et al. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1\u03b1-mediated glucose metabolism. Proc Natl Acad Sci USA. 2014;111:279\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7429_CR60","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00018-020-03524-9","volume":"77","author":"G Carr\u00e0","year":"2020","unstructured":"Carr\u00e0 G, Lingua MF, Maffeo B, Taulli R, Morotti A. P53 vs NF-\u03baB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa. Cell Mol Life Sci. 2020;77:4449\u201358.","journal-title":"Cell Mol Life Sci"},{"key":"7429_CR61","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1172\/JCI62229","volume":"122","author":"SY Ko","year":"2012","unstructured":"Ko SY, Barengo N, Ladanyi A, Lee JS, Marini F, Lengyel E, et al. HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. J Clin Investig. 2012;122:3603\u201317.","journal-title":"J Clin Investig"},{"key":"7429_CR62","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1172\/JCI78440","volume":"125","author":"SM Park","year":"2015","unstructured":"Park SM, G\u00f6nen M, Vu L, Minuesa G, Tivnan P, Barlowe TS, et al. Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program. J Clin Investig. 2015;125:1286\u201398.","journal-title":"J Clin Investig"},{"key":"7429_CR63","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ccr.2012.08.028","volume":"22","author":"X Jiang","year":"2012","unstructured":"Jiang X, Huang H, Li Z, Li Y, Wang X, Gurbuxani S, et al. Blockade of miR-150 maturation by MLL-fusion\/MYC\/LIN-28 is required for MLL-associated leukemia. Cancer Cell. 2012;22:524\u201335.","journal-title":"Cancer Cell"},{"key":"7429_CR64","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","volume":"80","author":"L Xiao","year":"2020","unstructured":"Xiao L, Li X, Mu Z, Zhou J, Zhou P, Xie C, et al. FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155\/23a cluster-MXI1 feedback circuit in glioma. Cancer Res. 2020;80:3945\u201358.","journal-title":"Cancer Res"},{"key":"7429_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0367-6","volume":"9","author":"J Xiang","year":"2018","unstructured":"Xiang J, Hu Q, Qin Y, Ji S, Xu W, Liu W, et al. TCF7L2 positively regulates aerobic glycolysis via the EGLN2\/HIF-1\u03b1 axis and indicates prognosis in pancreatic cancer. Cell Death Dis. 2018;9:321.","journal-title":"Cell Death Dis"},{"key":"7429_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1435269","volume":"15","author":"T Gao","year":"2024","unstructured":"Gao T, Hao X, Zhang J, Huo M, Hu T, Ma T, et al. Transcription factor ZEB1 coordinating with NuRD complex to promote oncogenesis through glycolysis in colorectal cancer. Front Pharmacol. 2024;15:1435269.","journal-title":"Front Pharmacol"},{"key":"7429_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1456636","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang Y, Liu Q, Zeng A, Song L. Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key. Front Immunol. 2024;15:1456636.","journal-title":"Front Immunol"},{"key":"7429_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1091779","volume":"13","author":"D Zhou","year":"2022","unstructured":"Zhou D, Duan Z, Li Z, Ge F, Wei R, Kong L. The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment. Front Pharmacol. 2022;13:1091779.","journal-title":"Front Pharmacol"},{"key":"7429_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97292-6","volume":"11","author":"H Takahashi","year":"2021","unstructured":"Takahashi H, Kawabata-Iwakawa R, Ida S, Mito I, Tada H, Chikamatsu K. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma. Sci Rep. 2021;11:17789.","journal-title":"Sci Rep"},{"key":"7429_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1416472","volume":"12","author":"J Zhao","year":"2024","unstructured":"Zhao J, Jin D, Huang M, Ji J, Xu X, Wang F, et al. Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target. Front Cell Dev Biol. 2024;12:1416472.","journal-title":"Front Cell Dev Biol"},{"key":"7429_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.116007","volume":"234","author":"AG Alkhathami","year":"2023","unstructured":"Alkhathami AG, Sahib AS, Al Fayi MS, Fadhil AA, Jawad MA, Shafik SA, et al. Glycolysis in human cancers: emphasis circRNA\/glycolysis axis and nanoparticles in glycolysis regulation in cancer therapy. Environ Res. 2023;234:116007.","journal-title":"Environ Res"},{"key":"7429_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01740-y","volume":"20","author":"Z Gu","year":"2022","unstructured":"Gu Z, Yu C. Harnessing bioactive nanomaterials in modulating tumor glycolysis-associated metabolism. J Nanobiotechnol. 2022;20:528.","journal-title":"J Nanobiotechnol"},{"key":"7429_CR73","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.7150\/thno.95748","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J, Jia W, Zhou X, Ma Z, Liu J, Lan P. CBX4 suppresses CD8(+) T cell antitumor immunity by reprogramming glycolytic metabolism. Theranostics. 2024;14:3793\u2013809.","journal-title":"Theranostics"},{"key":"7429_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10393-x","volume":"22","author":"P Zhu","year":"2022","unstructured":"Zhu P, Liu G, Wang X, Lu J, Zhou Y, Chen S, et al. Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis. BMC Cancer. 2022;22:1283.","journal-title":"BMC Cancer"},{"key":"7429_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104325","volume":"25","author":"R Serna","year":"2022","unstructured":"Serna R, Ramrakhiani A, Hernandez JC, Chen CL, Nakagawa C, Machida T, et al. c-JUN inhibits mTORC2 and glucose uptake to promote self-renewal and obesity. iScience. 2022;25:104325.","journal-title":"iScience"},{"key":"7429_CR76","doi-asserted-by":"publisher","first-page":"27410","DOI":"10.1074\/jbc.M802418200","volume":"283","author":"MC Hsieh","year":"2008","unstructured":"Hsieh MC, Das D, Sambandam N, Zhang MQ, Nahl\u00e9 Z. Regulation of the PDK4 isozyme by the Rb-E2F1 complex. J Biol Chem. 2008;283:27410\u20137.","journal-title":"J Biol Chem"},{"key":"7429_CR77","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/ncb2309","volume":"13","author":"E Blanchet","year":"2011","unstructured":"Blanchet E, Annicotte JS, Lagarrigue S, Aguilar V, Clap\u00e9 C, Chavey C, et al. E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol. 2011;13:1146\u201352.","journal-title":"Nat Cell Biol"},{"key":"7429_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13046-024-02957-5","volume":"43","author":"M Pan","year":"2024","unstructured":"Pan M, Luo M, Liu L, Chen Y, Cheng Z, Wang K, et al. EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL. J Exp Clin Cancer Res. 2024;43:35.","journal-title":"J Exp Clin Cancer Res"},{"key":"7429_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0502-8","volume":"18","author":"W Dai","year":"2020","unstructured":"Dai W, Meng X, Mo S, Xiang W, Xu Y, Zhang L, et al. FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer. Cell Commun Signal. 2020;18:7.","journal-title":"Cell Commun Signal"},{"key":"7429_CR80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.lfs.2018.10.018","volume":"213","author":"H Cui","year":"2018","unstructured":"Cui H, Gao Q, Zhang L, Han F, Wang L. Knockdown of FOXK1 suppresses liver cancer cell viability by inhibiting glycolysis. Life Sci. 2018;213:66\u201373.","journal-title":"Life Sci"},{"key":"7429_CR81","doi-asserted-by":"publisher","first-page":"47985","DOI":"10.18632\/oncotarget.10103","volume":"7","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yun Y, Wu B, Wen L, Wen M, Yang H, et al. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription. Oncotarget. 2016;7:47985\u201397.","journal-title":"Oncotarget"},{"key":"7429_CR82","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1038\/onc.2016.150","volume":"35","author":"Y Ma","year":"2016","unstructured":"Ma Y, Yu C, Mohamed EM, Shao H, Wang L, Sundaresan G, et al. A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer. Oncogene. 2016;35:6132\u201342.","journal-title":"Oncogene"},{"key":"7429_CR83","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998;394:485\u201390.","journal-title":"Nature"},{"key":"7429_CR84","doi-asserted-by":"publisher","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","volume":"269","author":"GL Semenza","year":"1994","unstructured":"Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269:23757\u201363.","journal-title":"J Biol Chem"},{"key":"7429_CR85","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7150\/ijbs.65255","volume":"18","author":"Z Li","year":"2022","unstructured":"Li Z, Geng M, Ye X, Ji Y, Li Y, Zhang X, et al. IRF7 inhibits the Warburg effect via transcriptional suppression of PKM2 in osteosarcoma. Int J Biol Sci. 2022;18:30\u201342.","journal-title":"Int J Biol Sci"},{"key":"7429_CR86","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/neuonc\/noac231","volume":"25","author":"R Yang","year":"2023","unstructured":"Yang R, Zhang G, Dong Z, Wang S, Li Y, Lian F, et al. Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression. Neuro Oncol. 2023;25:635\u201347.","journal-title":"Neuro Oncol"},{"key":"7429_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04658-7","volume":"21","author":"H Zhao","year":"2023","unstructured":"Zhao H, Jiang R, Feng Z, Wang X, Zhang C. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression. J Transl Med. 2023;21:833.","journal-title":"J Transl Med"},{"key":"7429_CR88","doi-asserted-by":"publisher","first-page":"8222","DOI":"10.1002\/cam4.4317","volume":"10","author":"D Zhang","year":"2021","unstructured":"Zhang D, Li Y, Yang S, Wang M, Yao J, Zheng Y, et al. Identification of a glycolysis-related gene signature for survival prediction of ovarian cancer patients. Cancer Med. 2021;10:8222\u201337.","journal-title":"Cancer Med"},{"key":"7429_CR89","doi-asserted-by":"publisher","first-page":"825.","DOI":"10.1038\/s41419-018-0887-0","volume":"9","author":"A Gupta","year":"2018","unstructured":"Gupta A, Ajith A, Singh S, Panday RK, Samaiya A, Shukla S. PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect. Cell Death Dis. 2018;9:825.","journal-title":"Cell Death Dis"},{"key":"7429_CR90","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ebiom.2018.12.038","volume":"40","author":"Y Shen","year":"2019","unstructured":"Shen Y, Zhao S, Wang S, Pan X, Zhang Y, Xu J, et al. S1P\/S1PR3 axis promotes aerobic glycolysis by YAP\/c-MYC\/PGAM1 axis in osteosarcoma. Ebiomedicine. 2019;40:210\u201323.","journal-title":"Ebiomedicine"},{"key":"7429_CR91","doi-asserted-by":"crossref","unstructured":"He T-L, Zhang Y-J, Jiang H, Li X-h, Zhu H, Zheng K-L. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. Med Oncol. 2015;32:187.","DOI":"10.1007\/s12032-015-0633-8"},{"key":"7429_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2072-5","volume":"10","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, He R, Jiang Y, Liu D, Tao L, Yang M, et al. Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1. Cell Death Dis. 2019;10:948.","journal-title":"Cell Death Dis"},{"key":"7429_CR93","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1038\/s41388-023-02760-0","volume":"42","author":"J Gao","year":"2023","unstructured":"Gao J, Fang Y, Chen J, Tang Z, Tian M, Jiang X, et al. Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy. Oncogene. 2023;42:2507\u201320.","journal-title":"Oncogene"},{"key":"7429_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200705","volume":"9","author":"X Zhang","year":"2022","unstructured":"Zhang X, Luo F, Luo S, Li L, Ren X, Lin J, et al. Transcriptional repression of aerobic glycolysis by OVOL2 in breast cancer. Adv Sci. 2022;9:e2200705.","journal-title":"Adv Sci"},{"key":"7429_CR95","doi-asserted-by":"publisher","first-page":"596.","DOI":"10.3390\/ijms21020596","volume":"21","author":"H Ramos","year":"2020","unstructured":"Ramos H, Calheiros J, Almeida J, Barcherini V, Santos S, Carvalho ATP, et al. SLMP53-1 inhibits tumor cell growth through regulation of glucose metabolism and angiogenesis in a P53-dependent manner. Int J Mol Sci. 2020;21:596.","journal-title":"Int J Mol Sci"},{"key":"7429_CR96","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/cas.13928","volume":"110","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Niu W, Luo Y, Li H, Xie Y, Wang H, et al. p53\/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53. Cancer Sci. 2019;110:939\u201349.","journal-title":"Cancer Sci"},{"key":"7429_CR97","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1038\/onc.2017.265","volume":"36","author":"J Kim","year":"2017","unstructured":"Kim J, Xu S, Xiong L, Yu L, Fu X, Xu Y. SALL4 promotes glycolysis and chromatin remodeling via modulating HP1\u03b1-Glut1 pathway. Oncogene. 2017;36:6472\u201379.","journal-title":"Oncogene"},{"key":"7429_CR98","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1172\/JCI62891","volume":"123","author":"A Li","year":"2013","unstructured":"Li A, Yang Y, Gao C, Lu J, Jeong HW, Liu BH, et al. A SALL4\/MLL\/HOXA9 pathway in murine and human myeloid leukemogenesis. J Clin Investig. 2013;123:4195\u2013207.","journal-title":"J Clin Investig"},{"key":"7429_CR99","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/hep.26159","volume":"57","author":"T Oikawa","year":"2013","unstructured":"Oikawa T, Kamiya A, Zeniya M, Chikada H, Hyuck AD, Yamazaki Y, et al. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology. 2013;57:1469\u201383.","journal-title":"Hepatology"},{"key":"7429_CR100","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1158\/0008-5472.CAN-20-4163","volume":"81","author":"L Du","year":"2021","unstructured":"Du L, Li Y, Kang M, Feng M, Ren Y, Dai H, et al. USP48 is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 stabilization. Cancer Res. 2021;81:3822\u201334.","journal-title":"Cancer Res"},{"key":"7429_CR101","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-15-2498","volume":"76","author":"SH Park","year":"2016","unstructured":"Park SH, Ozden O, Liu G, Song HY, Zhu Y, Yan Y, et al. SIRT2-mediated deacetylation and tetramerization of pyruvate kinase directs glycolysis and tumor growth. Cancer Res. 2016;76:3802\u201312.","journal-title":"Cancer Res"},{"key":"7429_CR102","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.7150\/thno.55330","volume":"11","author":"F Zhou","year":"2021","unstructured":"Zhou F, Zhang L, Zhu K, Bai M, Zhang Y, Zhu Q, et al. SIRT2 ablation inhibits glucose-stimulated insulin secretion through decreasing glycolytic flux. Theranostics. 2021;11:4825\u201338.","journal-title":"Theranostics"},{"key":"7429_CR103","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ccell.2018.01.010","volume":"33","author":"L Li","year":"2018","unstructured":"Li L, Liang Y, Kang L, Liu Y, Gao S, Chen S, et al. Transcriptional regulation of the Warburg effect in cancer by SIX1. Cancer Cell. 2018;33:368\u201385.e7.","journal-title":"Cancer Cell"},{"key":"7429_CR104","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3892\/ijo.2014.2767","volume":"46","author":"J Li","year":"2015","unstructured":"Li J, Liu T, Zhao L, Chen W, Hou H, Ye Z, et al. Ginsenoside 20(S)-Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells. Int J Oncol. 2015;46:775\u201381.","journal-title":"Int J Oncol"},{"key":"7429_CR105","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3748\/wjg.v25.i16.1936","volume":"25","author":"Y-H Bi","year":"2019","unstructured":"Bi Y-H, Han W-Q, Li R-F, Wang Y-J, Du Z-S, Wang X-J, et al. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions. World J Gastroenterol. 2019;25:1936\u201349.","journal-title":"World J Gastroenterol"},{"key":"7429_CR106","doi-asserted-by":"publisher","first-page":"24777","DOI":"10.18632\/oncotarget.15801","volume":"8","author":"M Li","year":"2017","unstructured":"Li M, Jin R, Wang W, Zhang T, Sang J, Li N, et al. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells. Oncotarget. 2017;8:24777\u201384.","journal-title":"Oncotarget"},{"key":"7429_CR107","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.cellsig.2014.03.020","volume":"26","author":"P Yang","year":"2014","unstructured":"Yang P, Li Z, Fu R, Wu H, Li Z. Pyruvate kinase M2 facilitates colon cancer cell migration via the modulation of STAT3 signalling. Cell Signal. 2014;26:1853\u201362.","journal-title":"Cell Signal"},{"key":"7429_CR108","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41418-024-01295-5","volume":"31","author":"D Wang","year":"2024","unstructured":"Wang D, Du G, Chen X, Wang J, Liu K, Zhao H, et al. Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer. Cell Death Differ. 2024;31:779\u201391.","journal-title":"Cell Death Differ"},{"key":"7429_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05157-1","volume":"13","author":"W Zhu","year":"2022","unstructured":"Zhu W, Wang J, Liu X, Xu Y, Zhai R, Zhang J, et al. lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma. Cell Death Dis. 2022;13:703.","journal-title":"Cell Death Dis"},{"key":"7429_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119715","volume":"1871","author":"F Lin","year":"2024","unstructured":"Lin F, Ma L, Yu S, Lin J, Xu Z, Xia H, et al. GLUT3 transcriptional activation by ZEB1 fuels the Warburg effect and promotes ovarian cancer progression. Biochim Biophys Acta Mol Cell Res. 2024;1871:119715.","journal-title":"Biochim Biophys Acta Mol Cell Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07429-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07429-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07429-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:11:22Z","timestamp":1739848282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07429-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7429"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07429-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This review needs neither ethical review nor an ethical statement. It contains no clinical data as no human clinical research was done on tumour patients or healthy subjects, nor non-clinical data like that from tumour cell line or animal tumour model experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have gone through the manuscript and agreed to publish in Cell Death & Disease.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"106"}}